Nephros (NEPH) Inventory (2010 - 2026)

Nephros' Inventory history runs 17 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• On a quarterly basis, Inventory rose 85.21% year-over-year to $3.6 million in Q1 2026; TTM through Mar 2026 was $3.6 million, a 85.21% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 23.59% from the prior year.
• Inventory rose to $3.6 million in Q1 2026 per NEPH's latest filing, from $3.2 million in the prior quarter.
• Across five years, Inventory topped out at $4.7 million in Q1 2022 and bottomed at $2.0 million in Q1 2025.
• The 5-year median for Inventory is $2.8 million (2024), against an average of $3.0 million.
• Across the five-year window, Inventory tumbled 54.42% in 2023 and jumped 85.21% in 2026, its largest moves.
• Year by year, Inventory stood at $3.2 million in 2022, then dropped by 21.66% to $2.5 million in 2023, then advanced by 5.87% to $2.6 million in 2024, then grew by 23.59% to $3.2 million in 2025, then rose by 11.97% to $3.6 million in 2026.
• Per Business Quant, the three latest NEPH Inventory figures stand at $3.6 million (Q1 2026), $3.2 million (Q4 2025), and $2.7 million (Q3 2025).